Overview
The goal of this pilot randomised controlled trial is to evaluate the effectiveness of the UniVRse VR-CBT programme in students with social anxiety. The aims of this trial are:
- To determine whether a full trial is justified;
- To establish the effect size on the co-primary outcomes for a sample size calculation for a definitive trial;
- To address questions concerning study recruitment, retention, and acceptability.
Participants will complete a baseline assessment (T0) and then be randomly allocated to receive either UniVRse VR-CBT or join the wait-list control group. UniVRse VR-CBT uses graded exposure techniques delivered using VR to help students feel more confident in university-based situations. Data will be collected post-intervention (T1) along with exit interviews to assess participant experience.
Eligibility
Inclusion Criteria:
For participants to be eligible to take part, they must be:
- A current student at the University of Westminster;
- Able to read and communicate in English;
- Wanting help to feel more confident at university;
- Deemed to have context-specific social anxiety as defined by a response of 'moderate'
or 'often' on one of the subscales from any one of the following items from the
MLSAS-SR: 5, 12, 17, and 9. These items reflect the highest level (i.e. most
anxiety-invoking) of each of the four scenarios within the UniVRse programme:
- Asking a question in a lecture in person
- Delivering a presentation on your own in front of the class
- Speaking using my mic during online seminars
- Speaking up during small group discussions in person
Exclusion Criteria:
Persons will be excluded from the study if meet any of the following criteria:
- Have photosensitive epilepsy;
- Have a visual impairment that cannot be corrected with glasses;
- Have a balance disorder;
- Have a significant auditory impairment;
- Have current and active suicidal plans;
- Are currently accessing or have confirmed plans to access another psychological intervention during the course of the study.
Participants will be excluded from providing a saliva sample (required for the cortisol
measurement) if they meet any of the following criteria:
- Are pregnant;
- Currently breastfeeding;
- Taking any medications;
- Have any other serious medical condition;
- Think that they currently have COVID-19. These participants may still participate in
the wider UniVRse trial if they meet all of the aforementioned main trial
inclusion/exclusion criteria.